Pharma Aids Limited announced unaudited earnings results for the second quarter and six months ended December 2017. For the quarter, EPS was BDT 4.26 for October-December, 2017 as against BDT 2.90 for October-December, 2016. EPS was BDT 8.05 for July-December, 2017 as against BDT 4.90 for July-December, 2016. NOCFPS was BDT 3.35 for July-December, 2017 as against NOCFPS negative of BDT 1.03 for July-December, 2016. NAV per share was BDT 55.23 as on December 31, 2017 and BDT 49.53 as on June 30, 2017.